Search research articles
Contact Us
Filters
Showing results (291-300 of 310) with videos related to
Page
of 31
Sort By:
Epilepsia
|
May 20, 2025
Comparison of children and adults undergoing subdural grid electrode implantation or stereoelectroencephalography in a refractory epilepsy cohort from four European centers
Matea Rados, Shanice Beerepoot, Martin M Tisdall, et al.
Restorative Neurology and Neuroscience
|
January 7, 2017
Recent progress in translational research on neurovascular and neurodegenerative disorders
Hans-Ulrich Demuth, Rick M Dijkhuizen, Tracy D Farr, et al.
Journal of Medicinal Chemistry
|
April 27, 2026
Correction to "Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease"
Elsie C Yu, Hua Zhou, Xin Yan, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2026
Discovery of Potent 1,3-Cyclobutane-Containing Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonists with Low Projected Human Dose for the Treatment of Cancer
Zachary G Brill, Alec H Christian, Lorena Rico, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
The Review of Scientific Instruments
|
November 29, 2014
Status of the diagnostics development for the first operation phase of the stellarator Wendelstein 7-X
R König, W Biel, C Biedermann, et al.
Journal of Medicinal Chemistry
|
March 3, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing
Derun Li, David L Sloman, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 9, 2010
Purine derivatives as potent gamma-secretase modulators
Alexey Rivkin, Sean P Ahearn, Stephanie M Chichetti, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 310) with videos related to
Sort By:
Page
of 31
Epilepsia
|
May 20, 2025
Comparison of children and adults undergoing subdural grid electrode implantation or stereoelectroencephalography in a refractory epilepsy cohort from four European centers
Matea Rados, Shanice Beerepoot, Martin M Tisdall, et al.
Restorative Neurology and Neuroscience
|
January 7, 2017
Recent progress in translational research on neurovascular and neurodegenerative disorders
Hans-Ulrich Demuth, Rick M Dijkhuizen, Tracy D Farr, et al.
Journal of Medicinal Chemistry
|
April 27, 2026
Correction to "Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease"
Elsie C Yu, Hua Zhou, Xin Yan, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2026
Discovery of Potent 1,3-Cyclobutane-Containing Dual A<sub>2A</sub>/A<sub>2B</sub> Receptor Antagonists with Low Projected Human Dose for the Treatment of Cancer
Zachary G Brill, Alec H Christian, Lorena Rico, et al.
Journal of Medicinal Chemistry
|
March 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease
Elsie C Yu, Hua Zhou, Xin Yan, et al.
Journal of Medicinal Chemistry
|
October 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Solomon D Kattar, Anmol Gulati, Kaila A Margrey, et al.
The Review of Scientific Instruments
|
November 29, 2014
Status of the diagnostics development for the first operation phase of the stellarator Wendelstein 7-X
R König, W Biel, C Biedermann, et al.
Journal of Medicinal Chemistry
|
March 3, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing
Derun Li, David L Sloman, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 9, 2010
Purine derivatives as potent gamma-secretase modulators
Alexey Rivkin, Sean P Ahearn, Stephanie M Chichetti, et al.
Journal of Medicinal Chemistry
|
September 4, 2024
Discovery and Optimization of N-Heteroaryl Indazole LRRK2 Inhibitors
Kaitlyn M Logan, Will Kaplan, Vladimir Simov, et al.
Page
of 31